Epilepsy and bipolar disorder

Epilepsy and Behavior

Volumn 52, Issue , 2015, Pages 267-274

  Knott, Sarah ^a   Forty, Liz ^a   Craddock, Nick ^a   Thomas, Rhys H ^a  

^a Cardiff University   (United Kingdom)

Author keywords

Bipolar disorder; Comorbidity; Epilepsy; Genetics

Indexed keywords

ANTICONVULSIVE AGENT; CALCIUM CHANNEL T TYPE;

ANXIETY; BIPOLAR DISORDER; CACNA1C GENE; CLINICAL EVALUATION; CLINICAL FEATURE; COMORBIDITY; COPY NUMBER VARIATION; DEPRESSION; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFICACY; EPIDEMIOLOGICAL DATA; EPILEPSY; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; MENTAL STRESS; MOOD DISORDER; MYOCLONUS EPILEPSY; PATHOGENESIS; PATHOPHYSIOLOGY; PERSONALITY; PROGNOSIS; PROPHYLAXIS; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SUICIDAL BEHAVIOR; TEMPORAL LOBE EPILEPSY; COMPLICATION; GENETICS; PSYCHOLOGY;

ANTICONVULSANTS; BIPOLAR DISORDER; EPILEPSY; HUMANS;

EID: 84947039363     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2015.07.003     Document Type: Review

References (99)

1. Hesdoffer D.C., Kanner A.M. The FDA alert on suicidality and antiepileptic drugs: fire or false alarm?. Epilepsia 2009, 50(5):978-986.
2. Reid S. Current use of antiepileptic drugs is associated with an increased risk of suicidality in people with depression but not in people with epilepsy or bipolar disorder. Evid Based Ment Health 2011, 14(1):3.
3. Craddock N., Owen M.J. The beginning of the end for the Kraepelinian dichotomy. Br J Psychiatry 2005, 186:364-366.
4. Berg A.T., Berkovic S.F., Brodie M.J., Buchhalter J., Cross J.H., van Emde Boas W., et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 2010, 51(4):676-685.
5. Mula M., Marotta A.E., Monaco F. Epilepsy and bipolar disorders. Expert Rev Neurother 2010, 10(1):13-23.
6. Grunze H.C.R. Anticonvulsants in bipolar disorder. J Ment Health 2010, 19(2):127-141.
7. Geddes J.R., Miklowitz D.J. Treatment of bipolar disorder. Lancet 2013, 381(9878):1672-1682.
8. Amann B., Grunze H. Neurochemical underpinnings in bipolar disorder and epilepsy. Epilepsia 2005, 46(S4):26-30.
9. Kanner A.M. Depression in epilepsy: prevalence, clinical semiology, pathogenic mechanisms and treatment. Biol Psychiatry 2003, 54:388-398.
10. Baker G.A., Jacoby A., Chadwick D.W. The associations of psychopathology in epilepsy: a community study. Epilepsy Res 1996, 25:29-39.
11. Kanner A.M., Balabanov A. Depression and epilepsy: how closely related are they?. Neurology 2002, 58(8 S5):S27-S39.
12. Blum D., Reed M., Metz A. Prevalence of major affective disorders and manic/hypomanic symptoms in persons with epilepsy: a community survey. Neurology 2003, (S3):A-175.
13. Eden J., Toone B. Relationship between interictal psychopathology and the type of epilepsy. Results of a survey in general practice. Br J Psychiatry 1987, 151:95-101.
14. Robertson M.M., Channon S., Baker J. Depressive symptomatology in a general hospital sample of outpatients with temporal lobe epilepsy: a controlled study. Epilepsia 1994, 35(4):771-777.
15. Ottman R., Lipton R.B., Ettinger A.B., Cramer J.A., Reed M.L., Morrison A., et al. Comorbidities of epilepsy: results from the Epilepsy Comorbidities and Health (EPIC) survey. Epilepsia 2011, 52(2):308-315.
16. Wolf P. Manic episodes in epilepsy. Advances in epileptology: XIIIth Epilepsy International Symposium 1982, 237-240. Raven Press, New York. H. Akimoto, H. Kazamatsuri, M. Seino, A.A. Ward (Eds.).
17. Mazza M., Di Nicola M., Della Marca G., Janiri L., Bria P., et al. Bipolar disorder and epilepsy: a bidirectional relation? Neurobiological underpinnings, current hypotheses, and future research directions. Neuroscientist 2007, 13(4):392-404.
18. Ettinger A.B., Reed M.L., Goldberg J.F., Hirschfeld R.M. Prevalence of bipolar symptoms in epilepsy vs other chronic health disorders. Neurology 2005, 65:535-540.
19. Oswald P., Sourey D., Kasper S., Lecrubier Y., Montgomery S., Wyckaert S., et al. Current issues in bipolar disorder: a critical review. Eur Neuropsychopharmacol 2007, 17:687-695.
20. Pini S., deQueiroz V., Pagnin D., Pezawas L., Angst J., Cassano G.B., et al. Prevalence and burden of bipolar disorders in European countries. Eur Neuropsychopharmacol 2005, 15(4):425-434.
21. Angst J. The emerging epidemiology of hypomania and bipolar II disorder. J Affect Disord 1998, 50:143-151.
22. Hirschfeld R.M., WIlliams J.B.W., Spitzer R.L., Calabrese J.R., Flynn L., Keck P.E., et al. Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry 2000, 157(11):1873-1875.
23. Chang H.-J., Liao C.-C., Hu C.-J., Shen W.W., Chen T.-L. Psychiatric disorders after epilepsy diagnosis: a population-based retrospective cohort study. PLoS One 2013, 8(4):e59999.
24. Blumer D., Montouris G., Davies K. The interictal dysphoric disorder: recognition, pathogenesis, and treatment of the major psychiatric disorder of epilepsy. Epilepsy Behav 2005, 5:826-840.
25. Kanner A.M., Barry J.J. Is the psychopathology of epilepsy different from that of nonepileptic patients?. Epilepsy Behav 2001, 2:170-186.
26. Mula M., Jauch R., Cavanna A., Collimedaglia L., Barbagli D., Gaus V., et al. Clinical and psychopathological definition of the interictal dysphoric disorder of epilepsy. Epilepsia 2008, 49:650-656.
27. Moller H.J., Curtis V.A. The bipolar spectrum: diagnostic and pharmacologic considerations. Expert Rev Neurother 2004, 4(6 Suppl. 2):S3-S8.
28. Mula M. The interictal dysphoric disorder of epilepsy: a still open debate. Curr Neurol Neurosci Rep 2013, 13(6):355.
29. Amiri M., Hansen C.P. The interictal dysphoric disorder in patients with epilepsy: a doubtful disorder lacking diagnostic tools. Seizure 2015, 24:70-76.
30. Mula M., Monaco F. Antiepileptic drug-induced mania in patients with epilepsy: what do we know?. Epilepsy Behav 2006, 9:265-267.
31. Mula M., Schmitz B., Jauch R., Cavanna A., Cantello R., Monaco F., et al. On the prevalence of bipolar disorder in epilepsy. Epilepsy Behav 2008, 13(4):658-661.
32. Starkstein S.E., Boston J.D., Robinson R.G. Mechanisms of mania after brain injury: 12 case reports and review of the literature. J Nerv Ment Dis 1988, 176(2):87-100.
33. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2000, American Psychiatric Association, Washington, DC. 4th Text Revision ed.
34. De Oliveira G.N.M., Kummer A., Salgado J.V., Marchetti R.L., Teixeira A.L. Neuropsychiatric disorders of temporal lobe epilepsy. Rev Bras Neurol 2009, 45(1):15-23.
35. Reynolds J.R. Epilepsy: its symptoms, treatment and relation to other chronic convulsive disorders 1861, 39-77. Churchill, London.
36. Gowers R.W. Epilepsy and other convulsive disorders 1885, 101. William Wood & Co, New York.
37. Wilson S.A.K. Neurology 1940, 1486. Williams & Wilkins, Baltimore.
38. Sjobring H. Personality structures and development. Acta Psychiatr Scand 1973, 244:1-204.
39. Blumer D. Evidence supporting the temporal lobe epilepsy personality syndrome. Neurology 1999, 53(5):s9-s12. [supplement 2].
40. Devinsky O., Najjar S. Evidence against the existence of a temporal lobe epilepsy personality syndrome. Neurology 1999, 53(5):s13-s25. [supplement 2].
41. Gibbs F.A. Ictal and non-ictal psychiatric disorders in temporal lobe epilepsy. Nerv Ment Dis 1951, 113:522-528.
42. Gestaut H., Morin G., Leserve N. Etude du comportement des épileptiques psycho-moteurs dans l'intervalle de leurs crises. Ann Med Psychol 1955, 113:1-27.
43. Kluver H., Bray P.C. Preliminary analysis of functions of the temporal lobe in monkeys. Arch Neurol Psychiatry 1939, 42:979-1002.
44. Koepp M.J., Thomas R.H., Wandschneider B., Berkovic S.F., Schmidt D. Concepts and controversies of juvenile myoclonic epilepsy: still an enigmatic epilepsy. Expert Rev Neurother 2014, 14(7):819-831.
45. Gelisse P., Genton P., Samuelian J.C., Thomas P, Bureau M, et al. Psychiatric disorders in juvenile myoclonic epilepsy. Rev Neurol 2001, 57:297-302.
46. De Araújo Filho G.M., Pascalicchio T.F., Sousa P.D.S., Lin K., Ferreira Guilhoto L.M.F., Yacubian E.M.T. Psychiatric disorders in juvenile myoclonic epilepsy: a controlled study of 100 patients. Epilepsy Behav 2007, 10:437-441.
47. Moschetta S., Fiore L., Fuentes D., Gois J., Valente K. Personality traits in patients with juvenile myoclonic epilepsy. Epilepsy Behav 2011, 21:473-477.
48. Walsh J., Thomas R.H., Church C., Rees M.I., Marson A.G., Baker G.A. Executive functions and psychiatric symptoms in drug-refractory juvenile myoclonic epilepsy. Epilepsy Behav 2014, 35:72-77.
49. Lau C., Ettinger A.B., Hamberger S., Fanning K., Reed M.L. Do mood instability symptoms in epilepsy represent formal bipolar disorder?. Epilepsia 2012, 53:e37-e40.
50. Kanner A.M. Postictal phenomena in epilepsy. Behavioral aspects of epilepsy 2008, 105-116. Demos, New York. S.C. Schachter, G.L. Holmes, D.G.A. Kasteleijn-Nolst Trenitè (Eds.).
51. Carney C.P., Jones L.E. Medical comorbidity in women and men with bipolar disorders: a population-based controlled study. Psychosom Med 2006, 68(5):684-691.
52. Evans-Lacko S.E., Zeber J.E., Gonzalez J.M., Olvera R.L. Medical comorbidity among youth diagnosed with bipolar disorder in the United States. J Clin Psychiatry 2009, 70(10):1461-1466.
53. Moreira C.L.R.L., Brietzke E., Lafer B. General medical comorbidities in Brazilian outpatients with bipolar disorder type 1. Rev Psiq Clin 2011, 38(6):227-230.
54. Weber N.S., Fisher J.A., Cowan D.N., Niebuhr D.W. Psychiatric and general medical conditions comorbid with bipolar disorder in the National Hospital Discharge Survey. Psychiatr Serv 2011, 62(10):1152-1158.
55. Oreški I., Jakovljević M., Aukst-Margetić B., Crnčević Orlić Ž., Vuksan-Ćusa B. Comorbidity and multicomorbidity in patients with schizophrenia and bipolar disorder: similarities and differences 2012, 24(1):80-85.
56. Forty L., Ulanova A., Jones L., Jones I., Gordon-Smith K., Fraser C., et al. Comorbid medical illness in bipolar disorder. Br J Psychiatry 2014, 205(6):465-472.
57. Berkson J. Limitations of the application of fourfold tables to hospital data. Biometrics 1946, 2(3):47-53.
58. Thomas R.H., Berkovic S.F. The hidden genetics of epilepsy - a clinically important new paradigm. Nat Rev Neurol 2014, 10(5):283-292.
59. Smoller J.W., Finn C.T. Family, twin, and adoption studies of bipolar disorder. Am J Med Genet C Semin Med Genet 2003, 123C(1):48-58.
60. Ferreira M.A., O'Donovan M.C., Meng Y.A., Jones I.R., Ruderfer D.M., Jones L., et al. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet 2008, 40:1056-1058.
61. The Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium Genome-wide association study identifies five new schizophrenia loci. Nat Genet 2011, 43:969-976.
62. Psychiatric GWAS Consortium Bipolar Disorder Working Group Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet 2011, 43:977-983.
63. Cross-Disorder Group of the Psychiatric Genomics Consortium Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 2013, 381(9875):1371-1379.
64. Cichon S., Mühleisen T.W., Degenhardt F.A., Mattheisen M., Miró X., Strohmaier J., et al. Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorder. Am J Hum Genet 2011, 88:372-381.
65. Green E.K., Hamshere M., Forty L., Gordon-Smith K., Fraser C., Russell E., et al. Replication of bipolar disorder susceptibility alleles and identification of two novel genome-wide significant associations in a new bipolar disorder case-control sample. Mol Psychiatry 2013, 18(12):1302-1307.
66. Green E.K., Grozeva D., Forty L., Gordon-Smith K., Russell E., Farmer A., et al. Association at SYNE1 in both bipolar disorder and recurrent major depression. Mol Psychiatry 2013, 18(5):614-617.
67. O'Donovan M.C., Craddock N., Norton N., Williams H., Peirce T., Moskvina V., et al. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet 2008, 40:1053-1055.
68. Steinberg S., de Jong S., Mattheisen M., Costas J., Demontis D., Jamain S., et al. Common variant at 16p11.2 conferring risk of psychosis. Mol Psychiatry 2014, 19(1):108-114.
69. McMahon F.J., Akula N., Schulze T.G., Muglia P., Tozzi F., Detera-Wadleigh S.D., et al. Meta-analysis of genome-wide association data identifies a risk locus for major mood disorders on 3p21.1. Nat Genet 2010, 42(2):128-131.
70. Heinzen E.L., Depondt C., Cavalleri G.L., Ruzzo E.K., Walley N.M., Need A.C., et al. Exome sequencing followed by large-scale genotyping fails to identify single rare variants of large effect in idiopathic generalized epilepsy. Am J Hum Genet 2012, 91(2):293-302.
71. Heron S.E., Khosravani H., Varela D., Bladen C., Williams T.C., Newman M.R., et al. Extended spectrum of idiopathic generalized epilepsies associated with CACNA1H functional variants. Ann Neurol 2007, 62(6):560-568.
72. Cain S.M., Snutch T.P. Voltage-gated calcium channels in epilepsy. Jasper's basic mechanisms of the epilepsies 2012, 66-78. National Center for Biotechnology Information (US), Bethesda (MD). J.L. Noebels, M. Avoli, M.A. Rogawski (Eds.).
73. Epi4K Consortium, Epilepsy Phenome/Genome Project, Allen AS, Berkovic SF, Cossette P., et al. De novo mutations in epileptic encephalopathies. Nature 2013, 501(7466):217-221.
74. Edvardson S., Oz S., Abulhijaa F.A., Taher F.B., Shaag A., Zenvirt S., et al. Early infantile epileptic encephalopathy associated with a high voltage gated calcium channelopathy. J Med Genet 2013, 50(2):118-123.
75. Pippucci T., Parmeggiani A., Palombo F., Maresca A., Angius A., Crisponi L., et al. A novel null homozygous mutation confirms CACNA2D2 as a gene mutated in epileptic encephalopathy. PLoS One 2013, 8(12):e82154.
76. Vergult S., Dheedene A., Meurs A., Faes F., Isidor B., Janssens S., et al. Genomic aberrations of the CACNA2D1 gene in three patients with epilepsy and intellectual disability. Eur J Hum Genet 2014, 10.1038/ejhg.2014.141.
77. Smith K.R., Kopeikina K.J., Fawcett-Patel J.M., Leaderbrand K., Gao R., Schürmann B., et al. Psychiatric risk factor ANK3/ankyrin-G nanodomains regulate the structure and function of glutamatergic synapses. Neuron 2014, 84(2):399-415.
78. Johnson M.R., Shorvon S.D. Heredity in epilepsy: neurodevelopment, comorbidity, and the neurological trait. Epilepsy Behav 2011, 22(3):421-427.
79. Georgieva L., Rees E., Moran J.L., Chambert K.D., Milanova V., Craddock N., et al. De novo CNVs in bipolar affective disorder and schizophrenia. Hum Mol Genet 2014, 23(24):6677-6678.
80. Green E.K., Rees E., Walters J.T., Smith K.G., Forty L., Grozeva D., et al. Copy number variation in bipolar disorder. Mol Psychiatry 2015, 10.1038/mp.2014.174.
81. Noor A., Lionel A.C., Cohen-Woods S., Moghimi N., Rucker J., Fennell A., et al. Copy number variant study of bipolar disorder in Canadian and UK populations implicates synaptic genes. Am J Med Genet B Neuropsychiatr Genet 2014, 165B(4):303-313.
82. Mullen S.A., Carvill G.L., Bellows S., Bayly M.A., Trucks H., Lal D., et al. Copy number variants are frequent in genetic generalized epilepsy with intellectual disability. Neurology 2013, 81(17):1507-1514.
83. Bergen D.C. Preventable neurological diseases worldwide. Neuroepidemiology 1998, 17:67-73.
84. Begley C.E., Famulari M., Annegers J.F., Lairson D.R., Reynolds T.F., Coan S., et al. The cost of epilepsy in the United States: an estimate from population-based clinical and survey data. Epilepsia 2000, 41:342-351.
85. Murray C.J., Lopez A.D. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Global burden of disease and injury series 1996, vol. I. Harvard School of Public Health, Cambridge, MA.
86. Wyatt R.J., Henter I. An economic evaluation of manic-depressive illness - 1991. Soc Psychiatry Psychiatr Epidemiol 1995, 30:213-219.
87. Wiebe S., Bellhouse D.R., Fallahay C., Eliasziw M. Burden of epilepsy: the Ontario Health Survey. Can J Neurol Sci 1999, 26(4):263-270.
88. Pugh M.J., Zeber J.E., Copeland L.A., Tabares J.V., Cramer J.A. Psychiatric disease burden profiles among veterans with epilepsy: the association with health services utilization. Psychiatr Serv 2008, 59(8):925-928.
89. Bryant-Comstock L., Stender M., Devercelli G. Health care utilization and costs among privately insured patients with bipolar I disorder. Bipolar Disord 2002, 4:398-405.
90. Guo J.J., Keck P.E., Li H., Jang R., Kelton C.M. Treatment costs and health care utilization for patients with bipolar disorder in a large managed care population. Value Health 2008, 11(3):416-423.
91. Leidy N.K., Elixhauser A., Vickrey B., Means E., Willian M.K. Seizure frequency and the health-related quality of life of adults with epilepsy. Neurology 1999, 53(1):162-166.
92. Jacoby A. Stigma, epilepsy, and quality of life. Epilepsy Behav 2002, 3(6S2):10-20.
93. Robertson M.M. Suicide, parasuicide and epilepsy. Epilepsy: a comprehensive textbook 1997, 2141-2151. Lippincott-Raven, Philadelphia. J. Engel, T.A. Pedley (Eds.).
94. Harris E.C., Barraclough B. Suicide as an outcome for mental disorders: a meta-analysis. Br J Psychiatry 1997, 170:205-228.
95. Nilsson L., Ahlbom A., Farahmand B.Y., Asberg M., Tomson T. Risk factors for suicide in epilepsy: a case control study. Epilepsia 2002, 43:644-651.
96. Jacobs D.G., Jamison K.R., Baldessarini R.J., Fawcett J.A., Hendin H., Gutheil T.G. Suicide: clinical/risk management issues for the psychiatrist. CNS Spectr 2000, 5:32-48.
97. Christensen J., Vestergaard M., Mortensen P.B., Sidenius P., Agerbo E. Epilepsy and risk of suicide: a population-based case-control study. Lancet Neurol 2007, 6:693-698.
98. Jones J.E., Hermann B.P., Barry J.J., Gilliam F.G., Kanner A.M., Meador K.J. Rates and risk factors for suicide, suicide ideation, and suicide attempts in chronic epilepsy. Epilepsy Behav 2003, 4(3):31-38.
99. Thomas R.H., Mullins J.M., Hammond C.L., Smith P.E., Kerr M.P. The importance of the experiences of initial diagnosis and treatment failure when switching antiepileptic drugs. Epilepsy Behav 2013, 29(3):492-496.